China Shineway Pharmaceutical Group Limited (2877.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.84B |
| Enterprise Value | -1.02B |
| P/E Ratio | 6.79 |
| PEG Ratio | -1.85 |
| Price/Sales Ratio | 2.03 |
| Price/Book Ratio | 0.66 |
| Enterprise/Revenue | -0.69 |
| Enterprise/EBITDA | -2.32 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.3 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 3.14B |
| Revenue/Share | 3.5 |
| Gross Profit | 2.27B |
| EBITDA | 739.53M |
| Net Income | 949.95M |
| Diluted EPS | 1.26 |
Balance Sheet
| Total Cash | 7.54B |
| Total Cash/Share | 9.98 |
| Total Debt | 312.23M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 4.32 |
| Book Value Per Share | 10.86 |
Price History
| 52-Week Change | -0.83 |
| 52-Week High | 10.47 |
| 52-Week Low | 7.21 |
| Moving Average 50 Days | 8.17 |
| Moving Average 200 Days | 8.79 |
Statistics
| Average Volume | 1.37M |
| Shares Outstanding | 755.4M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.21 |
| Trailing Annual Dividend Yield | 17.03 |
| Payout Ratio | 0.52 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
